Cargando…
The metabolic vascular syndrome - guide to an individualized treatment
In ancient Greek medicine the concept of a distinct syndrome (going together) was used to label ‘a group of signs and symptoms’ that occur together and ‘characterize a particular abnormality and condition’. The (dys)metabolic syndrome is a common cluster of five pre-morbid metabolic-vascular risk fa...
Autores principales: | Hanefeld, Markolf, Pistrosch, Frank, Bornstein, Stefan R., Birkenfeld, Andreas L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882364/ https://www.ncbi.nlm.nih.gov/pubmed/26956847 http://dx.doi.org/10.1007/s11154-016-9345-4 |
Ejemplares similares
-
Shifting the Disease Management Paradigm From Glucose: What are the cons?
por: Hanefeld, Markolf, et al.
Publicado: (2009) -
Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers
por: Pistrosch, Frank, et al.
Publicado: (2021) -
Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes
por: Hanefeld, Markolf, et al.
Publicado: (2017) -
Is Hyperglycemia a Cardiovascular Risk Factor?
por: Pistrosch, Frank, et al.
Publicado: (2011) -
Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study
por: Hanefeld, Markolf, et al.
Publicado: (2007)